HMOs and Gut Development: New Clinical Evidence
Posted: May 24,2022
Human milk oligosaccharides, or HMOs, are a group of unique and diverse oligosaccharides, representing the third largest solid compound of human milk. With the advancement of technology and research activities, more HMOs are available for infant nutrition. A new randomised, controlled, double-blind, trial shows the beneficial effect of a blend of 5 specific HMOs on gut development in full term healthy infants.